These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6318725

  • 1. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
    Kaneto E, Sasaki H, Tamura I, Kurimura O, Kurimura T.
    Biken J; 1983 Jun; 26(2):99-102. PubMed ID: 6318725
    [Abstract] [Full Text] [Related]

  • 2. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP, Baxevanis CN, Papadopoulos NG, Zarkadis IK, Papacostas P, Michailakis E, Tsiatas ML, Papamichail M.
    Anticancer Res; 1996 Jun; 16(6B):3855-60. PubMed ID: 9042270
    [Abstract] [Full Text] [Related]

  • 3. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
    Uchida A, Micksche M.
    J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
    [Abstract] [Full Text] [Related]

  • 4. [Production of a cytotoxic factor into malignant pleural fluid by OK-423, a streptococcal preparation--kinetic analysis].
    Yoshinaga T, Nomura H, Nishimura H, Tomino S, Kawakita M, Takatsuki K, Fujimoto K, Etou Y, Nakaji T, Kiyama T.
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2675-7. PubMed ID: 3740864
    [No Abstract] [Full Text] [Related]

  • 5. Treating carcinomatous pleural effusion by intrapleural injection of OK-432 in patients with non-small-cell lung cancer.
    Chao TY, Hwang WS.
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Oct; 52(4):229-34. PubMed ID: 8258114
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T, Takahashi N, Terakado M, Sato M, Sugane T, Kisohara A, Akusawa H, Tsujino I, Horie T.
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
    [Abstract] [Full Text] [Related]

  • 7. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
    Marumo K, Mura M, Deguchi N, Baba S, Jitsukawa S, Nakazono M, Tazaki H.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2434-9. PubMed ID: 3729498
    [Abstract] [Full Text] [Related]

  • 8. [Enhancing effects on interferon-gamma production by combination of OK-432 and interferon-alpha in patients with head and neck cancer].
    Sugiyama M, Morisaki N, Konishi K, Go K, Sugita M, Nakai Y.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2200-6. PubMed ID: 6435540
    [Abstract] [Full Text] [Related]

  • 9. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R, Shin DM, Siddik ZH, Murphy WK, Huber M, Lee SJ, Khokhar AR, Hong WK.
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [Abstract] [Full Text] [Related]

  • 10. [Cellular changes in malignant pleural effusion induced by intrapleural injection of BCG-CWS].
    Matsuda M, Morishita T, Horai T, Ikegami H, Nakamura S, Nishio H.
    Gan No Rinsho; 1983 Aug; 29(9):955-61. PubMed ID: 6620573
    [Abstract] [Full Text] [Related]

  • 11. [Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
    Mukai M, Den N, Yamazaki Y, Namiki S, Oda S, Nagao K.
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):96-102. PubMed ID: 6820880
    [Abstract] [Full Text] [Related]

  • 12. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
    Ishida A, Miyazawa T, Miyazu Y, Iwamoto Y, Zaima M, Kanoh K, Sumiyoshi H, Doi M.
    Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
    [Abstract] [Full Text] [Related]

  • 13. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
    Kasahara K, Shibata K, Shintani H, Iwasa K, Sone T, Kimura H, Nobata K, Hirose T, Yoshimi Y, Katayama N, Ishiura Y, Kita T, Nishi K, Nakatsumi Y, Ryoma Y, Fujimura M, Nakao S.
    Anticancer Res; 2006 Jan; 26(2B):1495-9. PubMed ID: 16619563
    [Abstract] [Full Text] [Related]

  • 14. [Effect of intravenous treatment with OK-432 on the bone marrow in patients with lung cancer].
    Fujii M, Ishikawa M, Toki H.
    Gan No Rinsho; 1984 Mar; 30(3):230-2. PubMed ID: 6325756
    [Abstract] [Full Text] [Related]

  • 15. [Randomized controlled study of OK-432 in the treatment of cancerous pleurisy].
    Urata A, Nishimura M, Ota K.
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1497-503. PubMed ID: 6409006
    [Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].
    Kawaoka T, Yoshino S, Kondo H, Yamamoto K, Hazama S, Oka M.
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1565-7. PubMed ID: 16315870
    [Abstract] [Full Text] [Related]

  • 17. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
    Uchida A, Micksche M, Hoshino T.
    Cancer Immunol Immunother; 1984 Oct; 18(1):5-12. PubMed ID: 6333269
    [Abstract] [Full Text] [Related]

  • 18. [Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
    Hattori H, Mikuriya S, Mamiya T, Hatano K, Shiina T, Yamada T.
    Gan No Rinsho; 1988 Jun; 34(7):851-6. PubMed ID: 3135423
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
    Kimura Y, Toki H, Okabe K, Fujii M, Tamai M.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):95-100. PubMed ID: 3942400
    [Abstract] [Full Text] [Related]

  • 20. [Case of malignant melanoma of the external genitalia responding satisfactorily to a combination of local injection of OK-432 and chemotherapy].
    Satoh S, Suzuki A, Okamura H, Nishimura T.
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):140-5. PubMed ID: 6820877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.